J. Veys Pharma: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
J. Veys Pharma
Largest movements
- Cash +€24,714
up €24,714 (+91.1%), from €27,117 to €51,831
mainly Net result for the year (+€15,149) and Receivables within one year (+€4,299)
- Receivables within one year -€4,299
down €4,299 (-10.0%), from €43,143 to €38,844
of which Other amounts receivable: -€4,084
- Tangible fixed assets -€1,592
down €1,592 (-31.4%), from €5,068 to €3,476
of which Plant, machinery and equipment: -€1,246
- Reserves +€15,149
new in 2025: €15,149
- Trade debts +€3,084
up €3,084 (+1071.2%), from €288 to €3,372
- Tax, wage and social debts +€1,433
up €1,433 (+16.7%), from €8,591 to €10,025
- Gross operating margin -€58,909
down €58,909 (-71.9%), from €81,906 to €22,997
- Taxes -€10,059
down €10,059 (-56.8%), from €17,708 to €7,649
- Financial income +€2,122
up €2,122 (+7633.3%), from €28 to €2,150
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €75,327 | €94,994 | +€19,667 | +26.1% |
| Fixed assets | 21/28 | €5,068 | €3,476 | -€1,592 | -31.4% |
| Tangible fixed assets | 22/27 | €5,068 | €3,476 | -€1,592 | -31.4% |
| Plant, machinery and equipment | 23 | €1,948 | €701 | -€1,246 | -64.0% |
| Furniture and vehicles | 24 | €3,120 | €2,774 | -€346 | -11.1% |
| Current assets | 29/58 | €70,259 | €91,518 | +€21,259 | +30.3% |
| Amounts receivable within one year | 40/41 | €43,143 | €38,844 | -€4,299 | -10.0% |
| Trade receivables | 40 | €11,072 | €10,856 | -€215 | -1.9% |
| Other amounts receivable | 41 | €32,071 | €27,987 | -€4,084 | -12.7% |
| Cash at bank and in hand | 54/58 | €27,117 | €51,831 | +€24,714 | +91.1% |
| Deferred charges and accrued income | 490/1 | - | €844 | +€844 | |
| Total equity and liabilities | 10/49 | €75,327 | €94,994 | +€19,667 | +26.1% |
| Equity | 10/15 | €66,448 | €81,597 | +€15,149 | +22.8% |
| Contributions | 10/11 | €4,000 | €4,000 | = | 0.0% |
| Reserves | 13 | - | €15,149 | +€15,149 | |
| Distributable reserves | 133 | - | €15,149 | +€15,149 | |
| Profit (loss) carried forward | 14 | €62,448 | €62,448 | = | 0.0% |
| Amounts payable | 17/49 | €8,879 | €13,397 | +€4,518 | +50.9% |
| Amounts payable within one year | 42/48 | €8,879 | €13,397 | +€4,518 | +50.9% |
| Trade debts | 44 | €288 | €3,372 | +€3,084 | +1071.2% |
| Suppliers | 440/4 | €288 | €3,372 | +€3,084 | +1071.2% |
| Taxes, remuneration and social security | 45 | €8,591 | €10,025 | +€1,433 | +16.7% |
| Taxes | 450/3 | €8,591 | €10,025 | +€1,433 | +16.7% |
| Remuneration, social security and pensions | 62 | €0 | - | = | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,278 | €1,592 | +€314 | +24.5% |
| Other operating charges | 640/8 | €115 | €495 | +€380 | +330.5% |
| Gross operating margin | 9900 | €81,906 | €22,997 | -€58,909 | -71.9% |
| Operating profit (loss) | 9901 | €80,512 | €20,910 | -€59,602 | -74.0% |
| Financial income | 75/76B | €28 | €2,150 | +€2,122 | +7633.3% |
| Recurring financial income | 75 | €28 | €2,150 | +€2,122 | +7633.3% |
| Financial charges | 65/66B | €384 | €261 | -€122 | -31.9% |
| Recurring financial charges | 65 | €384 | €261 | -€122 | -31.9% |
| Profit (loss) for the period before taxes | 9903 | €80,156 | €22,798 | -€57,358 | -71.6% |
| Income taxes | 67/77 | €17,708 | €7,649 | -€10,059 | -56.8% |
| Profit (loss) for the period | 9904 | €62,448 | €15,149 | -€47,299 | -75.7% |
| Profit (loss) for the period to be appropriated | 9905 | €62,448 | €15,149 | -€47,299 | -75.7% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 6 October 2026 via checked.be.